Revitalise Your Lymphatic Health with LYMPHOGENiX
At LYMPHOGENiX, we are pioneers in lymphatic vessel regeneration. Our groundbreaking technology restores lymphatic function, addressing various medical conditions with transformative potential. From heart failure and pulmonary fibrosis to skin ageing, obesity, Alzheimer’s disease, and infertility—our innovative solutions are paving the way for improved health and vitality. Empowering patients to live fuller lives, one cutting-edge treatment at a time.
About
Leading the Way in Regenerative Medicine
LYMPHOGENiX is at the forefront of lymphatic vessel regeneration research, driving innovation to develop life-changing treatments.
Our team of seasoned experts combines extensive scientific knowledge with industry experience, united by a passion for creating meaningful clinical solutions. With strong international collaborations and unwavering support from global stakeholders, we are dedicated to shaping the future of regenerative medicine through our unique contributions and pioneering advancements.
Services
Bespoke Solutions in Lymphatic Regeneration
Our comprehensive service portfolio offers tailored solutions to meet diverse clinical and research needs.
Product Development and Applications
Infertility affects 1 in 6 adults, but there is hope. Research provides novel indication for infertility treatments targeting the regeneration of lymphatic vessels. Our proprietary cytokine cocktail can markedly increase lymphangiogenic effects in female reproductive organs, potentially offering therapeutic benefits against infertility.
01
Infertility treatment
Our Skin-ageing treatment is a cutting-edge solution for visible improvements of aging skin. By targeting lymphatic vessel regeneration, this treatment is more effective than traditional fibroblast treatments. We will begin by licensing our FRF (fibroblast-rejuvenating factor) to our trusted partners.
02
Skin-ageing treatment
We are proud to be at the forefront of research in Alzheimer's treatment. Our treatment is expected to improve amyloid-β clearance through lymphatic regeneration.
03
Alzheimer's Therapy
Our innovative heart failure treatment is proven to improve cardiac function by generating more lymphatic vessels than conventional methods, This technology is clinically tested and safe. The technology comes with an 8-year history of excellence inherited from a previous biotech start-up.
04
Heart Failure Treatment
Pulmonary Fibrosis
05
Pulmonary fibrosis currently does not have a cure. Our approach to pulmonary fibrosis is to recover fibrotic areas by activating lymphangiogenesis. We have three years of research into this modality and have demonstrated high therapeutic potential in non-clinical settings.
Revolutinise Lymphangiogeneic Cell Therapies
Tissue sample collected at our licensed clinic, hospitals or laboratories
Biopsy from patient or donor
1
Our core technology. Fibroblasts are stimulated by our fibroblast-rejuvenating factor (FRF) and acquire strong lymphangiogenic effects.
Rejuvenation of fibroblast
3
Fibroblast are cultured to expand at authorized & secure laboratories.
Fibroblast cell expansion
2
After essential checks, fibroblasts or the rejuvenated culture fluids are administrated via our proprietary injecting device around damaged tissue.
QC and administration
4
At LYMPHOGENiX, our unique company structure enables us to offer a range of services tailored to meet the needs of our customers. Our headquarters is based in the UK – the perfect location to drive global business development, while our innovative R&D function is based in Japan, ready to leverage the latest technology trends.
Our diverse and talented team is passionate about working together to bring cutting-edge solutions to our clients, and deliver measurable value to all people in the world.
Our Creative Founders.
I am proud to lead the team at LYMPHOGENiX, leveraging my years of expertise in stem cells and regenerative medicine. With a Ph.D. in Medicine from Tokyo Women's Medical University and experience leading a research team at Keio University, I bring a wealth of knowledge to our cutting-edge work. I was also a co-founder of Metcela Inc, where I focused on developing new treatments for heart disease. Additionally, I currently teach at Keio University, sharing my passion for regenerative medicine with the next generation of scientists.
Dr Takahiro Iwamiya
Founder / Director / Science
As the co-founder of LYMPHOGENiX, I am committed to providing the most innovative and cutting-edge solutions in the field of regenerative medicine. With over a decade of experience in global innovation management, I have developed a deep understanding of the needs of our clients. I have previously worked with companies like DefiniGEN, and I am familiar with the latest trends and advancements in the field. I'm grateful to have the opportunity to help usher in the next generation of regenerative medicine.
Dr Masashi Matsunaga
Founder / Director / Operations
Newsletter
LYMPHOGENiX established!!
Welcome to LYMPHOGENiX, the leader in regenerative medicine through lymphangiogenesis. Our R&D team is located in Japan, while our operations seeking investment are based in the UK. Launched in 2024, we are committed to global business development and advancing the field of regenerative medicine.
We are looking for investors
If you are interested in supporting LYMPHOGENiX and investing in the future of regenerative medicine, we welcome discussions to join our seed round investment opportunity. Our company is poised for growth, and we are actively seeking investors who are passionate about the field and dedicated to helping us advance our mission.
Join our global team!!
LYMPHOGENiX is a leading-edge regenerative medical company focused on developing innovative therapeutic options. As we continue to grow, we are searching for talented leaders to help guide us into the future. We are looking for experience in CXO positions, as well as business development managers and R&D scientists who are passionate about advancing the frontiers of science and technology.
R&D in Japan, operation globally from the UK
LYMPHOGENiX is leading the way in global business operations and investment management. Our R&D activities remain in Japan, where we conduct preclinical POC studies and file patents to protect our intellectual property. We believe in investing in the future by supporting entrepreneurial activities that push the boundaries of what is possible. Our team are experts committed to providing our clients with the best investment opportunities available.
Often referred to as the body's "drainage system," lymphatic vessels form an intricate network throughout the body. When these vessels are underdeveloped, blocked, or otherwise compromised, they can cause various physiological issues, potentially leading to severe conditions such as fibrosis and lymphoedema.
Recent advancements in lymphatic biology and pathology research have shed light on their role in diseases such as cancer, obesity, and lymphoedema. However, despite an increase in research publications in this field, the complexity of the lymphatic system poses significant challenges. These vessels feature delicate three-dimensional structures, and their markers can vary across organs, requiring advanced techniques for accurate evaluation.
Overview
-
Expert Experimental Knowledge
-
Providing the essential techniques and protocols for lymphatic research, such as cell isolation and culture, specific marker analysis, and immunostaining.
-
Introducing advanced technologies, including 3D imaging of lymphatic vessels and functional analyses.
-
-
Customised Reagents and Cell Products
-
Supplying tailored reagents and cell lines to meet specific research objectives, such as antibodies for targeted lymphatic markers.
-
Accelerating research by providing specialised resources that may be difficult to access elsewhere.
-
-
Collaborative Research and Contract Services
-
Working alongside researchers to strengthen the foundation of lymphatic studies.
-
Acting as a CRO (Contract Research Organisation) to support outsourced tasks such as animal studies and preclinical trials.
-
-
Data Analysis and Consultation
-
Assisting with complex data analysis to provide researchers with deeper insights.
-
Using AI and bioinformatics tools to efficiently handle large-scale data and deliver actionable results.
-
How LYMPHOGENiX Supports Researchers
LYMPHOGENiX offers the following analysis services:
-
In vitro Responsiveness Analysis
(e.g., evaluating lymphatic cell responses to specific stimuli) -
In vitro Expression and Production Evaluation
(e.g., analysing expression levels of lymphatic markers) -
Statistical Analysis
(e.g., confirming statistical significance of experimental data and preparing reports) -
Image Analysis
(e.g., 3D structural analysis of lymphatic vessels, quantification of fluorescence imaging)
Our Range of Contract Research Services
